Activation of Human T Cells by a Tumor Vaccine Infected With Recombinant Newcastle Disease Virus Producing IL-2

International Journal of Oncology - Greece
doi 10.3892/ijo_00000070
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Spandidos Publications

Related search

Efficacy of a Recombinant Genotype VII Vaccine Against Challenge With Velogenic Newcastle Disease Virus

Journal of Vaccines and Immunology
2016English

MicroRNA Expression Profiling in Newcastle Disease Virus-Infected DF-1 Cells by Deep Sequencing

Frontiers in Microbiology
Microbiology
2019English

Regulation of Bone by IL-17-producing T Cells

Japanese Journal of Clinical Immunology
2017English

Newcastle Disease Virus-Based Vectored Vaccine Against Poliomyelitis

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2018English

Comparative Haematology of Chickens and Turkeys Experimentally Infected With a Velogenic Newcastle Disease Virus

Nigerian Veterinary Journal
2019English

Negative Modulation of Suppressive HIV-specific Regulatory T Cells by IL-2 Adjuvanted Therapeutic Vaccine

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2017English

Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation

Frontiers in Immunology
AllergyImmunology
2019English

Comparison of the Immune Response Between Local Manufactured and Commercial Inactivated Newcastle Disease Virus Vaccine in a Challenge Trail With Field Isolated Newcastle Disease Virus

The Iraqi Journal of Veterinary Medicine
2018English

Interaction Between a Live Avian Pneumovirus Vaccine and Two Different Newcastle Disease Virus Vaccines in Broiler Chickens With Maternal Antibodies to Newcastle Disease Virus

Avian Pathology
Animal ScienceZoologyFood AnimalsImmunologyMicrobiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy